These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7674911)

  • 21. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.
    Markovic TP; Jenkins AB; Campbell LV; Furler SM; Kraegen EW; Chisholm DJ
    Diabetes Care; 1998 May; 21(5):687-94. PubMed ID: 9589225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dexfenfluramine on free fatty acid turnover and oxidation in obese patients with type 2 diabetes mellitus.
    Greco AV; Mingrone G; Capristo E; De Gaetano A; Ghirlanda G; Castagneto M
    Metabolism; 1995 Feb; 44(2 Suppl 2):57-61. PubMed ID: 7869940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and insulin resistance: lessons learned from the Pima Indians.
    Lillioja S; Bogardus C
    Diabetes Metab Rev; 1988 Aug; 4(5):517-40. PubMed ID: 3061759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity.
    Ferrannini E; Camastra S
    Eur J Clin Invest; 1998 Sep; 28 Suppl 2():3-6; discussion 6-7. PubMed ID: 9777320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose-dependent insulinotropic polypeptide promotes lipid deposition in subcutaneous adipocytes in obese type 2 diabetes patients: a maladaptive response.
    Thondam SK; Daousi C; Wilding JP; Holst JJ; Ameen GI; Yang C; Whitmore C; Mora S; Cuthbertson DJ
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E224-E233. PubMed ID: 28073779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus.
    Blaak EE
    Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
    Boden G
    Diabetes; 1997 Jan; 46(1):3-10. PubMed ID: 8971073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.
    Lillioja S; Mott DM; Spraul M; Ferraro R; Foley JE; Ravussin E; Knowler WC; Bennett PH; Bogardus C
    N Engl J Med; 1993 Dec; 329(27):1988-92. PubMed ID: 8247074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular defects in glucose metabolism in obese patients with NIDDM.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the relative effects of obesity and non-insulin-dependent diabetes mellitus on in vivo insulin-stimulated glucose utilization.
    Hollenbeck CB; Chen YD; Reaven GM
    Diabetes; 1984 Jul; 33(7):622-6. PubMed ID: 6376218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes.
    Boden G; Sargrad K; Homko C; Mozzoli M; Stein TP
    Ann Intern Med; 2005 Mar; 142(6):403-11. PubMed ID: 15767618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals.
    Golay A; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1081-8. PubMed ID: 3517028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.